# Replimune, Inc. – FDA Inspection, Apr 24, 2025

Source: https://www.keypedia.com/records/fda_inspections/replimune-inc/6e72960b-1cc8-4ac3-847c-514786a66b44
Source feed: FDA_Inspections

> FDA inspection 1275618 of Replimune, Inc., April 24, 2025. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1275618
- Company Name: Replimune, Inc.
- Inspection Date: 2025-04-24
- Product Type: Biologics
- Center: Biologics
- Office Name: New England District Office
- Citation Count: 0

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/bo-liang/9902f822-7544-4e11-8cdc-49a99627db13)
- [Issuing Officer](https://www.keypedia.com/people/carla-a-lorenzo/049d09e7-bf75-4af5-8812-b13492cd72e3)
- [Issuing Officer](https://www.keypedia.com/people/guo-chiuan-hung/5ff55dcf-5a60-4c10-ac0a-0cabec7cec02)
- [Issuing Officer](https://www.keypedia.com/people/sharmila-shrestha/0a91aac0-76a5-4105-a23b-e0966f1aec0e)
- [Company Rep](https://www.keypedia.com/people/wei-wang/943039ac-3917-4d32-9f58-1886c56aecdd)

Company: https://www.keypedia.com/companies/replimune-inc/aed2f3d2-d153-4e38-af9b-19febd6fd927

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144
